Taking into account the association of impaired autophagy with the accumulation of amyloid-beta and tau proteins, the participation of PPAR-γ in the regulation of autophagy further highlights its potential as a therapeutic target in Alzheimer’s disease [78]. Here, MAPT is linked to early-onset autosomal dominant Alzheimer disease.